An immunologist puts the benefits of a new Russian vaccine against birch pollen allergy.
For the treatment of Allergarda, five to seven injections are enough, unlike previous drugs.
About 10% of the patients encountered side effects, noted Vladimir Bolivok in an interview with the "Moscow Speaks" radio station.
This is the first vaccine of the subunit, that is, it is the first vaccine of a new generation. This design is used for the first time in the world. The results obtained in clinical trials are very good. They offer a big advantage: the vaccine can be given in five to seven injections. This is a very good result, because old generation vaccines required between 15 and 50 injections to reach the desired result. This vaccine makes it possible to reduce the number of side effects, and as far as I remember from the instructions, something like 10% of all patients experienced some kind of side effect. With old vaccines, almost half of the patients experienced various adverse reactions.